Ohio Administrative Code
3701 - Department of Health - Administration and Director
Chapter 3701-55 - Newborn Screening for Genetic, Endocrine, or Metabolic Disorders
Section 3701-55-07 - Required further screening or diagnostic testing if specimen abnormal
§ 3701-55-07. Required further screening or diagnostic testing if specimen abnormal
This rule prescribes the procedures that apply if, upon screening of a specimen, the bureau of public health laboratory determines that the result indicates potential risk for one or more of the screened disorders.
(A) The director shall communicate the results to the following person, as applicable:
(1) If a child was born in a hospital or freestanding birthing center, the director shall communicate the results to the child's attending physician, child's primary medical provider, pediatrician, certified nurse midwife, certified nurse practitioner or clinical nurse specialist. If the director is unable to contact the attending physician, child's primary medical provider, pediatrician, certified nurse midwife, certified nurse practitioner or clinical nurse specialist, the director shall communicate the results to the newborn screening coordinator at the facility where the child was born.
(2) If the child was not born in a hospital or freestanding birthing center, the director shall communicate the results to the person designated in paragraph (A)(2) or (A)(3) of rule 3701-55-05 of the Administrative Code, as applicable.
(B) The person notified of the results by the director under paragraph (A) of this rule shall communicate the results to the child's parent, legal guardian, or legal custodian and shall obtain and submit a repeat blood specimen for screening or diagnostic testing in accordance with the following procedures:
(1) When the result indicates potential risk for a disorder listed in paragraphs (A)(1) to (A)( 36) of rule 3701-55-02 of the Administrative Code, a screening or diagnostic test shall be obtained in accordance with paragraph (B)(3) of this rule as soon as possible, but no later than ten days after notification by the director.
(2) When the results are abnormal for a hemoglobin disease or hemoglobin trait, a diagnostic test shall be obtained in accordance with paragraph (B)(3) of this rule before the child reaches two months of age.
(3) Diagnostic specimens obtained under paragraphs (B)(1) and (B)(2) of this rule shall be submitted for testing to a laboratory certified under the Clinical Laboratory Improvement Act, 42 USC 263a as amended January 24, 2004, that reports results with normal pediatric reference ranges. That laboratory shall promptly transmit the results of the diagnostic test to the person who submitted the specimen.
(C) If after ten business days, the person responsible for obtaining and submitting the repeat specimen and/or diagnostic tests under paragraph (B) of this rule is unable to obtain a specimen from a newborn child with an initial screen result of a potential risk despite making a reasonable effort, he or she shall notify the health commissioner of the health district in which the mother, legal guardian, or legal custodian resides.
The health commissioner shall make a reasonable effort to locate the child and cause a second specimen to be obtained. If the health commissioner is not able to locate that child within thirty days, he or she may close the file.
(D) The health commissioner shall submit a report to the director, upon case closure, listing the names and other identifiers of newborns the health commissioner was unable to locate.(Effective: 02/13/2014
R.C. 119.032 review dates: 11/27/2013 and 11/15/2018
Promulgated Under: 119.03
Statutory Authority: 3701.501
Rule Amplifies: 3701.501
Prior Effective Dates: 2/15/1999, 3/17/03 (Emer.), 6/15/03, 8/16/04, 2/13/09)